维普中文期刊产品整合服务
18篇 您的检索式:作者名="ANARGYROU K"
    题名 作者 年代 出处 被引量
1Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents显示文摘Terpos E Anargyrou K Katodritou E 2012Int J Cancer2012,130,3:1
2Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib显示文摘Anargyrou K Terpos E Vassilakopoulos TP 2008Haematologica2008,93,3:1
3Impact of leukapheresis on early death rate in adult acute mye- loid leukemia presenting with hyperleukocytosis显示文摘BUG G ANARGYROU K TONN T 2007Transfusion2007,47,:1
4Impact of leukapheresis on early death rate in adult acutemyeloid leukemia presentingwith hyperleukocytosis显示文摘Bug G Anargyrou K Tom T 2007Transfusion2007,47,10:1
5Impact of leuka- pheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis显示文摘Bug G Anargyrou K Tom T 2007Transfusion2007,47,10:1
6Novelanti-myeloma agents and angiogenesis显示文摘ANARGYROU K DINOPOULOS MA SEZER O 2008Leuk Lymphoma2008,49,4:1
7Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis显示文摘BUG G ANARGYROU K TONN T 2007Transfusion2007,47,:1
8An unusual case of CD4+ CD7+ CD56+ acute leukemia with overlapping features of type 2 dendritic cell (DC2) and myeloid/NK cell precursor acute leukemia显示文摘Anargyrou K Paterakis G Boutsis D 2003Eur J Haematol2003,71,4:1
9Incorporating novel agents in the treatment of myelodysplastic syndromes显示文摘ANARGYROU K VASSILAKOPOULOS TP ANGELOPOULOU MK 2010Leuk Res2010,34,1:1
10Novel anti-myeloma agents and angiogenesis 显示文摘Anargyrou K Dimopoulos MA Sezer O 2008Leuk Lymphoma2008,49,4:1
11Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis 显示文摘Bug G Anargyrou K Tom T 2007Transfusion2007,47,10:1
12Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents显示文摘Terpos E Anargyrou K Katodritou E 2012Int J Cancer2012,130,3:1
13Novel anti-myeloma agents and angiogenesis 显示文摘Anargyrou K Dimopoulos MA Sezer O 2008Leuk Lymphoma2008,49,4:1
14Incorporating novel agents in the treatment of myelodys- plastic syndromes显示文摘Anargyrou K Vassilakopoulos TP Angelopoulou MK 2010Leuk Res2010,34,:1
15Incorporating novel agents in the treat- ment of myelodysplastic syndromes 显示文摘Anargyrou K Vassilakopoulos TP Angelopoulou MK 2010Leuk Res2010,34,1:1
16Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia 显示文摘Giamarellos-Bourboulis EJ Grecka P Poulakou G Anargyrou K Katsilambros N Giamarellou H 2001Clin Infect Dis2001,32,12:1
17Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory resistant multiple myeloma patients treated with borte- zomib 显示文摘Anargyrou K Terpos E V assilakopoulos TP 2008Haematologica2008,93,3:1
18Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis显示文摘BUG G ANARGYROU K TOM T 2007Transfusion2007,47,10:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费